Manhattan Cardiology

New York, United States Founded: 2010 • Age: 16 yrs
Operates a chain of cardiology clinics for patient care.

About Manhattan Cardiology

Manhattan Cardiology is a Healthcare company based in New York (United States) founded in 2010 by Robert Segal. It operates a chain of cardiology clinics for patient care. It operates on a B2C model. Manhattan Cardiology has completed 1 acquisition, including Yafferuden. Its chief executive, as recorded, is Robert Segal. Its focus areas include Medical Services, Cardiology and Clinics. Its competitors include Novocardia, HeartPlace and National Cardiovascular Partners; 1 of its 3 listed competitors has raised funding.

Company details

Manhattan Cardiology operates a chain of cardiology clinics for patient care through providing healthcare solutions, medical services, cardiology, and clinics. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics

Apps and channels of Manhattan Cardiology

its YouTube channel Manhattan Cardiology has 378 subscribers and 26 videos.

Manhattan Cardiology
YouTube 378 subscribers 26 videos Howto & Style
Open channel

Videos from Manhattan Cardiology

The most watched videos on Manhattan Cardiology's YouTube channel, Manhattan Cardiology (378 subscribers). Click a video to play it here.

Manhattan Cardiology - #EveryBeatCounts - Short 2019
342.2K views
What is Low Blood Pressure? | Manhattan Cardiology
47.9K views
What Is A Stroke Screening? | Dr. Jossef Amirian | Manhattan Cardiology
6.8K views
What is an Exercise Stress Test? | Dr. Jossef Amirian | Manhattan Cardiology
2.8K views

More on Manhattan Cardiology.

People of Manhattan Cardiology

1 people are tracked at Manhattan Cardiology (1 in leadership).

NameRoleGroup
Robert Segal
Founder, CEOLeadership
Premium access

Complete people profiles for Manhattan Cardiology

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Manhattan Cardiology

Manhattan Cardiology has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Yafferuden.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Multi-specialty medical services and diagnostic testing are provided.
yafferuden.com0May 2018β€’β€’β€’β€’
Premium access

Complete acquisition details for Manhattan Cardiology

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Manhattan Cardiology

2 dated milestones of Manhattan Cardiology across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Manhattan Cardiology is founded.
  2. Acquisition Acquires Yafferuden.

Competitors of Manhattan Cardiology

Manhattan Cardiology has 3 listed competitors in our database, 1 of them funded. They include Novocardia, HeartPlace and National Cardiovascular Partners.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
novocardiahealth.com2020New York, United States$53.7M
Provider of value-based cardiovascular care models. It develops and implements models that improve the quality, cost, and patient experience of cardiovascular care. This includes programs for heart failure management, site-of-service optimization, and care transition interventions. The models utilize technology and analytics to enhance care coordination, reduce hospitalizations, and improve efficiency. Partnerships with physicians and payers are key to its approach, focusing on achieving better outcomes at a lower cost.
heartplace.com1961Dallas, United States
A chain of cardiology clinics is operated nationwide.
ncplp.com2004Houston, United States
Chain of general clinics
Premium access

Detailed competitors of Manhattan Cardiology

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Manhattan Cardiology

Websites that share an audience with Manhattan Cardiology (manhattancardiology.com).

Similar websites

Websites whose visitors overlap most with Manhattan Cardiology. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
nortonhealthcare.com
79%
404.6K#149,583View details
imaware.health
53%
26.4K#1,137,505View details

Top companies in Cardiac and Vascular Disorders

3 companies that operate in the same segment as Manhattan Cardiology (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Manhattan Cardiology

Manhattan Cardiology was founded in 2010.

Manhattan Cardiology is headquartered in New York, United States. It is registered at New York, New York, United States.

Robert Segal is the CEO of Manhattan Cardiology, as recorded in our data. They have also founded this company.

Manhattan Cardiology operates a chain of cardiology clinics for patient care through providing healthcare solutions, medical services, cardiology, and clinics. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Manhattan Cardiology's top competitors include National Cardiovascular Partners, HeartPlace and Novocardia.

Manhattan Cardiology has made 1 acquisition, including Yafferuden.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available